EU to fund transfer of COVID-19 patients across borders to prevent hospitals collapse | Inquirer News
Close  

EU to fund transfer of COVID-19 patients across borders to prevent hospitals collapse

/ 07:44 AM October 30, 2020

European Commission President Ursula Von Der Leyen gives a news briefing at the end of a virtual conference with EU leaders about EU government’s measures against the coronavirus disease (COVID19) crisis, in Brussels, Belgium, October 29, 2020. Olivier Hoslet/Pool via REUTERS

BRUSSELS — The European Union will finance the transfer of patients across borders within the bloc to prevent hospitals from getting overwhelmed as COVID-19 infections and hospitalizations spike in the continent.

After a video conference of EU leaders to discuss the health crisis on Thursday, the head of the EU Commission Ursula von der Leyen said the EU executive had made available 220 million euros ($260 million) to move COVID-19 patients across borders.

ADVERTISEMENT

“The spread of the virus will overwhelm our healthcare systems if we do not act urgently,” she said.

At the meeting leaders agreed to better coordinate efforts to battle the virus as infections in Europe exceeded 10 million, making the continent again the epicenter of the pandemic.

FEATURED STORIES

EU countries want to avoid divisions which dogged the 27-nation bloc at the beginning of the pandemic, when nations vied with each other to buy scarce medical equipment.

To better trace infections, von der Leyen said the EU would work for the quick validation at EU level of rapid antigen tests, which allow quicker results than the standard PCR (polymerase chain reaction) molecular kits.

The Commission is also intensifying its efforts to get potential vaccines against the new coronavirus.

The EU was in talks with four companies, and had already sealed supply deals with another three, she said.

The EU has secured potential vaccines being developed by AstraZeneca, Sanofi and Johnson & Johnson.

It has also said it is in talks with Moderna, CureVac and a partnership of Pfizer and BionTech. Reuters reported in September that the EU was also in preliminary talks with Novavax.

The chair of the meeting, Charles Michel, said EU leaders committed to a fair distribution of vaccines once available. That would be done in proportion to population, von der Leyen said.

ADVERTISEMENT

Michel said vaccination plans at a national level were crucial to make sure the first limited doses of vaccines could be distributed quickly to those most in need.

Many countries however have not yet defined their inoculation plans, and have different targets.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: coronavirus pandemic, COVID-19, European Commission, European Union
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2020 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.